Roivant Sciences Ltd (NASDAQ: ROIV) on Tuesday, soared 4.75% from the previous trading day, before settling in for the closing price of $21.9. Within the past 52 weeks, ROIV’s price has moved between $8.73 and $22.56.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -99.51%. The company achieved an average annual earnings per share of -376.85%. With a float of $437.46 million, this company’s outstanding shares have now reached $689.70 million.
Considering the fact that the conglomerate employs 750 people, you should pay attention to its efficiency factor.
Roivant Sciences Ltd (ROIV) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Roivant Sciences Ltd is 37.10%, while institutional ownership is 63.74%. The most recent insider transaction that took place on Dec 12 ’25, was worth 43,389,842. In this transaction 10% Owner of this company sold 1,975,858 shares at a rate of $21.96, taking the stock ownership to the 36,350,621 shares. Before that another transaction happened on Dec 11 ’25, when Company’s 10% Owner sold 774,142 for $21.64, making the entire transaction worth $16,752,433. This insider now owns 34,749,305 shares in total.
Roivant Sciences Ltd (ROIV) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.2 earnings per share (EPS) for the period topping the consensus outlook (set at -0.24) by 0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -376.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -25.94% during the next five years compared to -99.51% drop over the previous five years of trading.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Roivant Sciences Ltd (ROIV) is currently performing well based on its current performance indicators. A quick ratio of 33.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 784.78.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.55, a number that is poised to hit -0.31 in the next quarter and is forecasted to reach -1.32 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Compared to the last year’s volume of 6.61 million, its volume of 12.63 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 83.23%.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 97.69%, which indicates a significant increase from 91.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.76 in the past 14 days, which was higher than the 0.52 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.53, while its 200-day Moving Average is $13.59. Nevertheless, the first resistance level for the watch stands at $23.51 in the near term. At $24.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $24.94. If the price goes on to break the first support level at $22.08, it is likely to go to the next support level at $21.23. Now, if the price goes above the second support level, the third support stands at $20.66.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
Market capitalization of the company is 15.95 billion based on 695,492K outstanding shares. Right now, sales total 29,050 K and income totals -171,980 K. The company made 1,570 K in profit during its latest quarter, and -113,520 K in sales during its previous quarter.
